Where does Genvax Technologies's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Genvax Technologies's 2 recorded funding rounds.

Premier Alternatives

Genvax Technologies

Ames, IA · Founded 2021 · Privately Held (backing)

Developer of animal vaccines designed to accelerate treatments for the animal health industry. Genvax Technologies is based in Ames, IA and was founded in 2021. Its last reported valuation was $25 million in Aug 2022. It has raised $8.4 million across 2 recorded rounds; the latest was a $3.4 million seed round in Jun 2024.

Last reported valuation

$25.0M

Oct 2026

Priced at

—

Total raised

$8.4M

Last round

Seed Round

Jun 2024

Cap table — not yet on record

Genvax Technologies's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Genvax Technologies with a free account

·The complete investor list: 11 names
·Watch Genvax Technologies: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Genvax Technologies

Where does Genvax Technologies's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Genvax Technologies's 2 recorded funding rounds.